1587 related articles for article (PubMed ID: 10772968)
41. Current controversies in the treatment of ductal carcinoma in situ of the breast.
Franceschini G; Terribile D; Magno S; Fabbri C; D'Alba P; Chiesa F; Di Leone A; Scafetta I; Masetti R
Ann Ital Chir; 2008; 79(3):151-5. PubMed ID: 18958961
[TBL] [Abstract][Full Text] [Related]
42. Predictors of local recurrence following excision alone for ductal carcinoma in situ.
Hetelekidis S; Collins L; Silver B; Manola J; Gelman R; Cooper A; Lester S; Lyons JA; Harris JR; Schnitt SJ
Cancer; 1999 Jan; 85(2):427-31. PubMed ID: 10023711
[TBL] [Abstract][Full Text] [Related]
43. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data.
Porembka MR; Abraham RL; Sefko JA; Deshpande AD; Jeffe DB; Margenthaler JA
Ann Surg Oncol; 2008 Oct; 15(10):2709-19. PubMed ID: 18483831
[TBL] [Abstract][Full Text] [Related]
44. In situ ductal carcinoma of the breast--analysis of clinical presentation and outcome in 156 consecutive cases.
Ciatto S; Grazzini G; Iossa A; Del Turco MR; Bravetti P; Cataliotti L; Cardona G; Bianchi S
Eur J Surg Oncol; 1990 Jun; 16(3):220-4. PubMed ID: 2161353
[TBL] [Abstract][Full Text] [Related]
45. Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ.
Bijker N; Peterse JL; Duchateau L; Robanus-Maandag EC; Bosch CA; Duval C; Pilotti S; van de Vijver MJ
Br J Cancer; 2001 Feb; 84(4):539-44. PubMed ID: 11207051
[TBL] [Abstract][Full Text] [Related]
46. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
[TBL] [Abstract][Full Text] [Related]
47. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
48. Current management of ductal carcinoma in situ of the breast.
Mokbel K
Int J Clin Oncol; 2003 Feb; 8(1):18-22. PubMed ID: 12601537
[TBL] [Abstract][Full Text] [Related]
49. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
[TBL] [Abstract][Full Text] [Related]
50. Intraductal carcinoma of the breast.
von Rueden DG; Wilson RE
Surg Gynecol Obstet; 1984 Feb; 158(2):105-11. PubMed ID: 6320480
[TBL] [Abstract][Full Text] [Related]
51. [Ductal carcinoma in situ of the breast (DCIS) under 40: a specific management?].
Tunon de Lara C
Gynecol Obstet Fertil; 2008 May; 36(5):499-506. PubMed ID: 18467151
[TBL] [Abstract][Full Text] [Related]
52. The role of excision and surveillance alone in subclinical DCIS of the breast.
Schwartz GF
Oncology (Williston Park); 1994 Feb; 8(2):21-6; discussion 26-7, 31-2, 35. PubMed ID: 8167086
[TBL] [Abstract][Full Text] [Related]
53. [Surgical aspects of breast cancer screening at our hospital].
Márkus B; Bajner A; Csejtei A; Firisz B; Hegedus A; Kocsis E; Kovács B; Pintér G; Tóth C
Magy Seb; 2006 Oct; 59(5):375-82. PubMed ID: 17201346
[TBL] [Abstract][Full Text] [Related]
54. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
[TBL] [Abstract][Full Text] [Related]
55. High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS.
Roka S; Rudas M; Taucher S; Dubsky P; Bachleitner-Hofmann T; Kandioler D; Gnant M; Jakesz R
Eur J Surg Oncol; 2004 Apr; 30(3):243-7. PubMed ID: 15028303
[TBL] [Abstract][Full Text] [Related]
56. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
[TBL] [Abstract][Full Text] [Related]
57. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
58. Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ.
Williamson D; Dinniwell R; Fung S; Pintilie M; Done SJ; Fyles AW
Radiother Oncol; 2010 Jun; 95(3):317-20. PubMed ID: 20400190
[TBL] [Abstract][Full Text] [Related]
59. Effectiveness of radiation therapy in older women with ductal carcinoma in situ.
Smith BD; Haffty BG; Buchholz TA; Smith GL; Galusha DH; Bekelman JE; Gross CP
J Natl Cancer Inst; 2006 Sep; 98(18):1302-10. PubMed ID: 16985249
[TBL] [Abstract][Full Text] [Related]
60. Ductal carcinoma in situ of the breast: correlation of pathologic and mammographic features with extent of disease.
Coombs JH; Hubbard E; Hudson K; Wunderlich C; VanMeter S; Bell JL; Gwin JL
Am Surg; 1997 Dec; 63(12):1079-83. PubMed ID: 9393256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]